US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist

1.480
-0.050-3.27%

Close May 3 16:00 ET

97.50MMarket Cap-747P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-20.10%-71.74M

-81.98%-22.8M

-19.79%-15.99M

-40.36%-18.26M

29.52%-14.69M

-46.95%-59.73M

34.90%-12.53M

-63.36%-13.35M

-39.26%-13.01M

-435.56%-20.84M

Net income from continuing operations

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

-5.27%-71.46M

5.81%-20.07M

-251.51%-15.69M

51.78%-18.5M

-359.02%-17.2M

Operating gains losses

-154.62%-331K

22.41%-405K

293.10%342K

-103.51%-10K

-1,390.00%-258K

59.25%-130K

-4,250.00%-522K

680.00%87K

283.87%285K

114.60%20K

Depreciation and amortization

40.00%756K

5.79%201K

63.03%194K

1,600.00%187K

-20.91%174K

26,900.00%540K

9,400.00%190K

12,000.00%119K

1,000.00%11K

--220K

Deferred tax

--0

----

--87K

----

Change In working capital

39.84%5.86M

-66.83%2.03M

910.49%2.16M

-70.89%1.12M

110.00%550K

640.21%4.19M

470.14%6.13M

82.72%-267K

1,398.31%3.83M

-49,900.00%-5.5M

-Change in prepaid assets

-65.75%1.57M

-237.11%-1.31M

-91.71%187K

-68.10%799K

266.23%1.89M

156.59%4.58M

125.08%954K

303.98%2.26M

177.17%2.51M

-1,822.73%-1.14M

-Change in payables and accrued expense

2,514.78%4.9M

-39.98%2.71M

184.72%2.1M

-77.29%464K

91.52%-363K

-102.77%-203K

-8.10%4.51M

-463.55%-2.47M

-30.77%2.04M

-5,457.14%-4.28M

-Change in other current assets

90.91%-4K

8.94%780K

0.00%22K

98.19%-14K

-8,700.00%-792K

-76.00%-44K

--716K

--22K

---773K

---9K

-Change in other current liabilities

-334.53%-604K

-200.00%-144K

-98.59%-141K

-343.64%-134K

-146.67%-185K

---139K

---48K

---71K

--55K

---75K

Cash from discontinued investing activities

Operating cash flow

-20.10%-71.74M

-81.98%-22.8M

-19.79%-15.99M

-40.36%-18.26M

29.52%-14.69M

-46.95%-59.73M

34.90%-12.53M

-63.36%-13.35M

-39.26%-13.01M

-435.56%-20.84M

Investing cash flow

Cash flow from continuing investing activities

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

-3,833.33%-118K

-107K

-116K

Net PPE purchase and sale

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

-3,833.33%-118K

---107K

---116K

Cash from discontinued investing activities

Investing cash flow

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

-3,833.33%-118K

---107K

---116K

Financing cash flow

Cash flow from continuing financing activities

71.86M

-10K

Net common stock issuance

--75.06M

--0

----

--0

----

Net other financing activities

---3.2M

---10K

----

Cash from discontinued financing activities

Financing cash flow

--71.86M

---10K

--71.87M

--0

Net cash flow

Beginning cash position

-32.55%142.86M

9.46%165.77M

-35.23%110.36M

-31.55%128.8M

-32.55%142.86M

6,120.23%211.8M

232.99%151.44M

211.20%170.39M

197.64%188.17M

6,120.23%211.8M

Current changes in cash

99.67%-200K

-78.00%-22.92M

514.79%55.86M

-39.51%-18.3M

29.21%-14.84M

-128.48%-60.42M

-107.66%-12.88M

-64.74%-13.47M

-40.40%-13.12M

-134.07%-20.96M

Effect of exchange rate changes

109.42%803K

-85.83%609K

91.80%-450K

97.19%-131K

129.06%775K

-126.77%-8.52M

334.68%4.3M

-398.00%-5.49M

-633.64%-4.66M

-56.97%-2.67M

End cash Position

0.42%143.46M

9.46%165.77M

-35.23%110.36M

-31.55%128.8M

-32.55%142.86M

232.99%151.44M

211.20%170.39M

197.64%188.17M

Free cash flow

-19.27%-72.06M

-77.92%-22.91M

-18.92%-16.01M

-39.51%-18.3M

29.21%-14.84M

-48.09%-60.42M

33.60%-12.88M

-64.74%-13.47M

-40.40%-13.12M

-438.54%-20.96M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-20.10%-71.74M	-81.98%-22.8M	-19.79%-15.99M	-40.36%-18.26M	29.52%-14.69M	-46.95%-59.73M	34.90%-12.53M	-63.36%-13.35M	-39.26%-13.01M	-435.56%-20.84M
Net income from continuing operations	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	-5.27%-71.46M	5.81%-20.07M	-251.51%-15.69M	51.78%-18.5M	-359.02%-17.2M
Operating gains losses	-154.62%-331K	22.41%-405K	293.10%342K	-103.51%-10K	-1,390.00%-258K	59.25%-130K	-4,250.00%-522K	680.00%87K	283.87%285K	114.60%20K
Depreciation and amortization	40.00%756K	5.79%201K	63.03%194K	1,600.00%187K	-20.91%174K	26,900.00%540K	9,400.00%190K	12,000.00%119K	1,000.00%11K	--220K
Deferred tax	--0	----	----	----	----	--87K	----	----	----	----
Change In working capital	39.84%5.86M	-66.83%2.03M	910.49%2.16M	-70.89%1.12M	110.00%550K	640.21%4.19M	470.14%6.13M	82.72%-267K	1,398.31%3.83M	-49,900.00%-5.5M
-Change in prepaid assets	-65.75%1.57M	-237.11%-1.31M	-91.71%187K	-68.10%799K	266.23%1.89M	156.59%4.58M	125.08%954K	303.98%2.26M	177.17%2.51M	-1,822.73%-1.14M
-Change in payables and accrued expense	2,514.78%4.9M	-39.98%2.71M	184.72%2.1M	-77.29%464K	91.52%-363K	-102.77%-203K	-8.10%4.51M	-463.55%-2.47M	-30.77%2.04M	-5,457.14%-4.28M
-Change in other current assets	90.91%-4K	8.94%780K	0.00%22K	98.19%-14K	-8,700.00%-792K	-76.00%-44K	--716K	--22K	---773K	---9K
-Change in other current liabilities	-334.53%-604K	-200.00%-144K	-98.59%-141K	-343.64%-134K	-146.67%-185K	---139K	---48K	---71K	--55K	---75K
Cash from discontinued investing activities
Operating cash flow	-20.10%-71.74M	-81.98%-22.8M	-19.79%-15.99M	-40.36%-18.26M	29.52%-14.69M	-46.95%-59.73M	34.90%-12.53M	-63.36%-13.35M	-39.26%-13.01M	-435.56%-20.84M
Investing cash flow
Cash flow from continuing investing activities	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K	-3,833.33%-118K	-107K	-116K
Net PPE purchase and sale	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K	-3,833.33%-118K	---107K	---116K
Cash from discontinued investing activities
Investing cash flow	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K	-3,833.33%-118K	---107K	---116K
Financing cash flow
Cash flow from continuing financing activities	71.86M	-10K				0	0
Net common stock issuance	--75.06M	--0	----	----	----	--0	--0	----	----	----
Net other financing activities	---3.2M	---10K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--71.86M	---10K	--71.87M	--0	--0	--0	--0	--0	--0	--0
Net cash flow
Beginning cash position	-32.55%142.86M	9.46%165.77M	-35.23%110.36M	-31.55%128.8M	-32.55%142.86M	6,120.23%211.8M	232.99%151.44M	211.20%170.39M	197.64%188.17M	6,120.23%211.8M
Current changes in cash	99.67%-200K	-78.00%-22.92M	514.79%55.86M	-39.51%-18.3M	29.21%-14.84M	-128.48%-60.42M	-107.66%-12.88M	-64.74%-13.47M	-40.40%-13.12M	-134.07%-20.96M
Effect of exchange rate changes	109.42%803K	-85.83%609K	91.80%-450K	97.19%-131K	129.06%775K	-126.77%-8.52M	334.68%4.3M	-398.00%-5.49M	-633.64%-4.66M	-56.97%-2.67M
End cash Position	0.42%143.46M	0.42%143.46M	9.46%165.77M	-35.23%110.36M	-31.55%128.8M	-32.55%142.86M	-32.55%142.86M	232.99%151.44M	211.20%170.39M	197.64%188.17M
Free cash flow	-19.27%-72.06M	-77.92%-22.91M	-18.92%-16.01M	-39.51%-18.3M	29.21%-14.84M	-48.09%-60.42M	33.60%-12.88M	-64.74%-13.47M	-40.40%-13.12M	-438.54%-20.96M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall